---
$id: https://graph.org.ai/products/commodity/51292006
$type: Product
source: UNSPSC
code: "51292006"
title: "Dapoxetine"
class: "51292000"
classTitle: "Antidepressant amines"
family: "51290000"
familyTitle: "Antidepressants"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dapoxetine

**UNSPSC Code**: 51292006
**Class**: [Antidepressant amines](Antidepressant amines.mdx)
**Family**: [Antidepressants](../Antidepressants.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a selective serotonin reuptake inhibitor and antidepressant agent with the molecular formula C21H23NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GB2433A4M3, chemically known as benzenemethanamine, n,n-dimethyl-alpha-(2-(1-naphthalenyloxy)ethyl)-, (+)- but generally known as dapoxetine, which bears US NIH Compound Identifier 71353. European Medicines Agency schedules Dapoxetine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06908MIG. The term DAPOXETINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 6, No, 3 1992, List 32). World Health Organization schedules dapoxetine in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule dapoxetine under HS 29221980 and SITC 51461. As of Q4 2014, DAPOXETINE remains the US FDA Preferred Term for this commodity. Dapoxetine bears US NLM identifiers UMLS ID C0215087 and NCI Concept Code C75168. SMILES: O(CCC(N(C)C)c1ccccc1)c1c2c(ccc1)cccc2.

